Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan.
Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Kanagawa, Japan.
Dig Endosc. 2020 Mar;32(3):399-408. doi: 10.1111/den.13497. Epub 2019 Sep 15.
In chronic pancreatitis (CP) patients, diagnosis of small pancreatic lesions by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is challenging. Thus, the aim of the present study was to investigate whether CP influences the diagnostic ability of EUS-FNA for pancreatic lesions ≤10 mm.
One hundred and seventeen patients who underwent EUS-FNA for pancreatic lesions ≤10 mm in size were enrolled. Patients were classified into two groups based on features of CP observed by EUS (EUS-CP features) in accordance with the Rosemont classification. The CP group was defined as cases consistent with CP or suggestive of CP, and the non-CP group was defined as cases indeterminate for CP or normal. Factors influencing the diagnostic accuracy of EUS-FNA and CP status in pancreatic tumors were also investigated.
Diagnostic ability of EUS-FNA (overall cases, non-CP vs CP) had sensitivity (80.4%, 96.7% vs 57.1%; P < 0.001), specificity (100%, 100% vs 100%; P > 0.05), and accuracy (91.5%, 98.6% vs 80.4%; P = 0.001). In multivariate analysis of factors influencing the accuracy of EUS-FNA, CP significantly lowered the accuracy (P = 0.048; odds ratio [OR] = 9.21). Among pancreatic cancer patients, the number of CP patients was significantly higher than the number of patients with benign lesions (P = 0.023). In multivariate analysis, lobularity without honeycombing was more frequently observed in cases of pancreatic cancer (P = 0.018; OR, 12.65).
Endoscopic ultrasound-guided FNA offers high accuracy for small pancreatic lesions ≤10 mm. However, in cases with CP, the diagnostic ability of EUS-FNA is significantly reduced.
在慢性胰腺炎(CP)患者中,经内镜超声引导下细针抽吸(EUS-FNA)诊断小胰腺病变具有挑战性。因此,本研究旨在探讨 CP 是否会影响 EUS-FNA 对≤10mm 胰腺病变的诊断能力。
纳入 117 例行 EUS-FNA 检查的≤10mm 胰腺病变患者。根据 Rosemont 分类,根据 EUS 观察到的 CP 特征(EUS-CP 特征)将患者分为两组。CP 组定义为符合 CP 或提示 CP 的病例,非 CP 组定义为不确定 CP 或正常的病例。还研究了影响 EUS-FNA 诊断准确性和 CP 状态的因素。
EUS-FNA(总体病例、非 CP 与 CP)的诊断能力具有敏感性(80.4%、96.7%与 57.1%;P<0.001)、特异性(100%、100%与 100%;P>0.05)和准确性(91.5%、98.6%与 80.4%;P=0.001)。在影响 EUS-FNA 准确性的多因素分析中,CP 显著降低了准确性(P=0.048;比值比[OR]9.21)。在胰腺癌患者中,CP 患者的数量明显高于良性病变患者(P=0.023)。在多因素分析中,无蜂巢状分叶更常发生于胰腺癌病例(P=0.018;OR,12.65)。
内镜超声引导下 FNA 对≤10mm 的小胰腺病变具有较高的准确性。然而,在 CP 病例中,EUS-FNA 的诊断能力显著降低。